Arrivent BioPharma, Inc. (AVBP)
22.82
-0.27
(-1.17%)
USD |
NASDAQ |
Feb 20, 12:11
Arrivent BioPharma EPS Diluted (Quarterly) : -0.8345 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | -1.203 |
| AIM ImmunoTech, Inc. | -1.567 |
| Bristol Myers Squibb Co. | 0.5326 |
| Annexon, Inc. | -0.3683 |
| Spruce Biosciences, Inc. | -14.58 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.98M |
| Total Expenses (Quarterly) | 34.98M |
| Enterprise Value | 652.98M |
| Earnings Yield | -18.56% |
| Normalized Earnings Yield | -18.56 |